US drugmakers’ fury over price probe demands
US drugmakers have reacted with fury to two separate calls by Members of Congress for official inquiries into allegations of industry “price gouging” in anticipation of health care reform.
Regulators on both sides of Atlantic review data on sibutramine
Regulators in the USA and Europe are reviewing preliminary data which suggests that patients taking Abbott Laboratories’ obesity drug Meridia have a higher number of cardiovascular events than those on placebo
Read more...
|